ATOPIC DERMATITIS RESEARCH NETWORK

特应性皮炎研究网络

• 批准号: 8159558
• 负责人: DAVID LEUNG
• 金额: $ 3185.96万
• 依托单位: NATIONAL JEWISH HEALTH
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-06-30 至 2015-06-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8159558
• 关键词: African American; American; Animal Experimentation; Animal Model; Animals; Area; Atopic Dermatitis; Attenuated; Blood Cells; Clinical; Clinical Research; Clinical Trials; Collaborations; Communicable Diseases; Cutaneous; Data; Defect; Disease; Eczema Herpeticum; Eczema Vaccinatum; Enrollment; European; FDA approved; Gene Expression Profiling; Genetic; Goals; Immune; Immune response; Immunologics; Individual; Infection; Laboratory Scientists; Medical center; Mexican Americans; Microbiology; Minnesota; Organism; Other Genetics; Patients; Physicians; Predisposition; Preparation; Protocols documentation; Quality Control; Race; Recombinant DNA; Recording of previous events; Registries; Research; Research Personnel; Research Support; Role; Sampling; Severity of illness; Simplexvirus; Skin; Staphylococcus aureus; Time; Universities; Vaccination; Vaccine Research; Vaccines; Viral Vaccines; Vitamin D; clinical research site; experience; genetic variant; human disease; influenzavirus; methicillin resistant Staphylococcus aureus; mouse model; null mutation; quality assurance; repository; response; skin disorder

The goal of the Atopic Dermatitis Research Network (ADRN) is to support clinical research and closely related animal research on the immunopathogenesis of atopic dermatitis (AD), the relevance of immunologic, skin barrier, genetic and other factors in this disease, as well as the underlying mechanisms for susceptibility of individuals with AD to cutaneous infectious diseases, including eczema vaccinatum (EV), eczema herpeticum (EH), and Staphylococcus aureus (SA) infections. The ADRN will also support research on responses to vaccines in individuals with AD.

特应性皮炎研究网络 (ADRN) 的目标是支持特应性皮炎 (AD) 的免疫发病机制、免疫学、皮肤屏障、遗传和其他因素与该疾病的相关性以及该疾病的临床研究和密切相关的动物研究。 AD 患者对皮肤传染病（包括牛痘湿疹 (EV)、疱疹湿疹 (EH) 和金黄色葡萄球菌）易感性的潜在机制（SA）感染。 ADRN 还将支持 AD 患者对疫苗反应的研究。